- Home
- ARMN vs CERT Comparison
ARMN vs CERT Comparison
Compare ARMN & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMN
- CERT
- Stock Information
- Founded
- ARMN 1992
- CERT 2008
- Country
- ARMN Canada
- CERT United States
- Employees
- ARMN N/A
- CERT N/A
- Industry
- ARMN
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- ARMN
- CERT Technology
- Exchange
- ARMN Nasdaq
- CERT Nasdaq
- Market Cap
- ARMN 2.0B
- CERT 1.9B
- IPO Year
- ARMN N/A
- CERT 2020
- Fundamental
- Price
- ARMN $10.79
- CERT $13.00
- Analyst Decision
- ARMN Strong Buy
- CERT Buy
- Analyst Count
- ARMN 1
- CERT 8
- Target Price
- ARMN $17.00
- CERT $15.57
- AVG Volume (30 Days)
- ARMN 2.1M
- CERT 2.0M
- Earning Date
- ARMN 11-11-2025
- CERT 11-05-2025
- Dividend Yield
- ARMN N/A
- CERT N/A
- EPS Growth
- ARMN N/A
- CERT N/A
- EPS
- ARMN 0.02
- CERT 0.05
- Revenue
- ARMN $646,783,000.00
- CERT $405,755,000.00
- Revenue This Year
- ARMN $49.45
- CERT $11.70
- Revenue Next Year
- ARMN $13.00
- CERT $8.05
- P/E Ratio
- ARMN $413.00
- CERT $261.22
- Revenue Growth
- ARMN 38.72
- CERT 11.61
- 52 Week Low
- ARMN $3.29
- CERT $8.64
- 52 Week High
- ARMN $10.87
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- ARMN 74.04
- CERT 62.65
- Support Level
- ARMN $9.67
- CERT $12.73
- Resistance Level
- ARMN $10.86
- CERT $13.88
- Average True Range (ATR)
- ARMN 0.40
- CERT 0.53
- MACD
- ARMN 0.04
- CERT 0.12
- Stochastic Oscillator
- ARMN 99.24
- CERT 71.02
About ARMN Aris Mining Corporation
Aris Mining Corp is engaged in the acquisition, exploration, development, and operation of gold properties in Colombia, Guyana, and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, the Toroparu Project in Guyana, and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.